Bk Cancer Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-10-2024
- Paid Up Capital ₹ 0.10 M
as on 27-10-2024
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2023
About Bk Cancer Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurang Modi, Itesh Khatwani, Rushabh Kothari, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ2022PTC137783
- Company No.
137783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Banaskantha, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bk Cancer Center?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurang Modi  | Director | 27-Dec-2022 | Current |
| Itesh Khatwani | Director | 09-Mar-2023 | Current |
| Rushabh Kothari | Director | 09-Mar-2023 | Current |
| Ghemarbhai Chaudhari | Director | 25-Mar-2023 | Current |
| Dipakkumar Chaudhary | Director | 27-Dec-2022 | Current |
| Manishkumar Patel | Director | 25-Mar-2023 | Current |
Financial Performance of Bk Cancer Center.
Bk Cancer Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bk Cancer Center?
Unlock access to Bk Cancer Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Oncowin Cancer Center LlpActive 3 years 9 monthsGaurang Modi, Itesh Khatwani and 1 more are mutual person
- Gir Pharma Research And Healthcare LlpActive 1 year 6 months
Gaurang Modi, Itesh Khatwani and 1 more are mutual person
- Oncowin Research & Development LlpActive 1 year 2 months
Gaurang Modi, Itesh Khatwani and 1 more are mutual person
- Akshar Pathology Laboratory Private LimitedActive 1 year 3 months
Ghemarbhai Chaudhari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bk Cancer Center?
Bk Cancer Center has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bk Cancer Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bk Cancer Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
